Your browser doesn't support javascript.
loading
Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial.
Zhao, Jingjing; Song, Changgeng; Li, Deshuai; Yang, Xiai; Yu, Liping; Wang, Kangjun; Wu, Jun; Wang, Xiaofeng; Li, Dongsong; Zhang, Bo; Li, Binyong; Guo, Jun; Feng, Weikui; Fu, Feng; Gu, Xinrong; Qian, Jian; Li, Jialong; Yuan, Xiangjun; Liu, Qiuwu; Chen, Jiang; Wang, Xiaocheng; Liu, Yi; Wei, Dong; Wang, Ling; Shang, Lei; Yang, Fang; Jiang, Wen.
Afiliação
  • Zhao J; Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Song C; Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Li D; Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Yang X; Department of Neurology, Ankang Central Hospital, Ankang 725000, China.
  • Yu L; Department of Neurology, The First People's Hospital of Xianyang, Xianyang 712000, China.
  • Wang K; Department of Neurology, Hanzhong Central Hospital, Hanzhong 723000, China.
  • Wu J; Department of Neurology, Xianyang Central Hospital, Xianyang 712000, China.
  • Wang X; Department of Neurosurgery, The PLA 987 Hospital, Baoji 721000, China.
  • Li D; Department of Neurology, Ankang People's Hospital, Ankang 725000, China.
  • Zhang B; Department of Neurology, Shangluo Central Hospital, Shangluo 726000, China.
  • Li B; Department of Neurology, Xixiang Hospital, Hanzhong 723000, China.
  • Guo J; Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
  • Feng W; Department of Neurology, Shaanxi Province Mianxian Hospital, Hanzhong 723000, China.
  • Fu F; Department of Neurology, 215 Hospital of Shaanxi NI, Xianyang 712021, China.
  • Gu X; Department of Neurology, Tianjin Hospital of Ningqiang, Hanzhong 723000, China.
  • Qian J; Department of Neurology, Xi'an No.4 Hospital, Xi'an 710004, China.
  • Li J; Department of Neurology, Baoji No.3 Hospital, Baoji 721000, China.
  • Yuan X; Department of Neurology, Weinan Central Hospital, Weinan 714000, China.
  • Liu Q; Department of Neurology, Xi'an 141 Hospital, Xi'an 710499, China.
  • Chen J; Department of Neurology, Shaanxi Aerospace Hospital, Xi'an 710025, China.
  • Wang X; Department of Neurology, Yulin No.2 Hospital, Yulin 719000, China.
  • Liu Y; Department of Neurology, Ankang Central Hospital, Ankang 725000, China.
  • Wei D; Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Wang L; Department of Health Statistics, Fourth Military Medical University, Xi'an, China.
  • Shang L; Department of Health Statistics, Fourth Military Medical University, Xi'an, China.
  • Yang F; Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Jiang W; The Shaanxi Cerebrovascular Disease Clinical Research Centre, Xi'an 710032, China.
EClinicalMedicine ; 53: 101666, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36177443
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article